Cachectin/tumor necrosis factor: An endogenous mediator of shock and inflammation

Bruce Beutler, Anthony Cerami

Research output: Contribution to journalArticlepeer-review

86 Scopus citations


During the past 3 years, cachectin (TNF) has come to be regarded as a proximal mediator of inflammation, which exerts powerful effects on the metabolic activities of host tissues during infection. In the future, it is anticipated that a growing understanding of cachectin and its role in mammalian physiology will yield important advances in basic and clinical science. A precise knowledge of the hormone's mechanism of action may shed light on the causes of inflammation, its benefits and its liabilities. The unusual ability of cachectin to lyse tumor cells in vitro may ultimately lead to the design of effective antineolastic agents. Finally, the molecular events involved that govern the induction of cachectin gene expression by LPS may prove to be very general. Thus, studies of cachectin gene expression may lead to a broader understanding of the central mechanisms by which transcription and translation are effected in mammalian cells.

Original languageEnglish (US)
Pages (from-to)281-293
Number of pages13
JournalImmunologic Research
Issue number4
StatePublished - Dec 1986

ASJC Scopus subject areas

  • Immunology


Dive into the research topics of 'Cachectin/tumor necrosis factor: An endogenous mediator of shock and inflammation'. Together they form a unique fingerprint.

Cite this